Skip to main content
Clinical Trials/JPRN-UMIN000023420
JPRN-UMIN000023420
Recruiting
未知

A study to evaluate pregnancy outcome and to establish a registration database of pregnant women with preexisting diabetes and gestational diabetes mellitus(GDM) :a multicenter, prospective study -Diabetes and Pregnancy Outcome for Mother and Baby Study,GDM-Pregnant Outcome study[DREAMBee study,GDM-PO] - DREAMBee study[GDM-PO]

The Japanese Society of Dianetes and Pregnancy0 sites1,800 target enrollmentAugust 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Gestational diabetes mellitus(GDM)
Sponsor
The Japanese Society of Dianetes and Pregnancy
Enrollment
1800
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
The Japanese Society of Dianetes and Pregnancy

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not applicable

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Prospective study to evaluate the clinical outcome of POEM combined with endoscopic anti-reflux surgery.
JPRN-UMIN000028567Showa University Koto Toyosu Hospital100
Not yet recruiting
Not Applicable
A preliminary study to evaluate effectiveness of Korean medicine treatment for periodontal disease
KCT0009294Dongguk University Ilsan Oriental Hospital45
Active, not recruiting
Phase 1
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.Rheumatoid ArthritisMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2010-020065-24-ESF. Hoffmann-La Roche Ltd.2,800
Active, not recruiting
Phase 1
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.Rheumatoid ArthritisMedDRA version: 16.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2010-020065-24-BEF. Hoffmann-La Roche Ltd.3,080
Active, not recruiting
Phase 1
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.Rheumatoid ArthritisMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2010-020065-24-GRF. Hoffmann-La Roche Ltd.2,800